Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
The current price of 23E1.MU is €13.54 EUR — it has increased by +0% in the past 24 hours. Watch ChronoScale stock price performance more closely on the chart.
What is ChronoScale stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ChronoScale stocks are traded under the ticker 23E1.MU.
When is the next ChronoScale earnings date?▼
ChronoScale is going to release the next earnings report on August 03, 2026.
In which sector is ChronoScale located?▼
ChronoScale operates in the Other sector.
When did ChronoScale complete a stock split?▼
The last stock split for ChronoScale was on June 02, 2025 with a ratio of 1:15.